Fundación GECP   Report issue

Foundation Phase 2 Phase 3
Founded: Barcelona Spain (1991)

Organization Overview

First Clinical Trial
2019
NCT03838159
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fundación GECP | Fundación GECP Investigator | Fundación GECP President